Filing Details
- Accession Number:
- 0001437749-17-015179
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-08-22 18:19:27
- Reporting Period:
- 2017-08-22
- Accepted Time:
- 2017-08-22 17:19:27
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1427925 | Acelrx Pharmaceuticals Inc | ACRX | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1511365 | P Pamela Palmer | C/O Acelrx Pharmaceuticals, Inc. 351 Galveston Drive Redwood City CA 94063 | Chief Medical Officer | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2017-08-22 | 10,000 | $2.95 | 415,801 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Footnotes
- This is a weighted average purchase price. Shares were purchased in the range of $2.9250 and $2.95.
- Balance includes non-reportable acquisition of 6,786 shares of Common Stock through the Company's Employee Stock Purchase Plan.
Billionaire Hedge Funds
